-
2024-517411-73-00
6
2025-11-12
Patient with medium or high risk for pneumococcal invasive infection
-
2024-517708-12-00
5
2025-11-07
Severe burns
-
2023-506843-40-00
5
2025-10-29
Mycobacterium xenopi pulmonary infection
-
2024-515178-28-00
9
2025-09-23
Hepatocellular carcinoma
-
2023-510262-27-00
4
2025-06-24
newly diagnosed or relapsing deep venous thrombosis related to Behçet’
-
2024-513771-40-01
7
2025-03-03
chronic renal failure requiring kidney transplantation
-
2022-502624-44-00
5
2024-12-10
kidney transplantation
-
2024-516109-21-00
5
2024-12-09
Polycythaemia Vera (PV)
-
2023-508704-37-00
5
2024-11-08
Stroke
-
2024-511507-42-00
4
2024-11-08
30 adult patients due to receive an allograft for a myeloid or lymphoi
-
2024-515219-23-00
3
2024-11-08
multiple myeloma
-
2022-501019-15-00
9
2024-10-22
Acute Leukemia
-
2023-508614-41-00
4
2024-10-15
The study will be proposed to all adult patients receiving an allogene
-
2024-514107-34-00
4
2024-07-18
BRAF V600E-MUTATED LOCALISED COLON OR UPPER RECTUM CANCER
-
2023-508178-27-00
9
2024-07-10
Participants with Advanced KRASG12C-Mutated Solid Tumors
-
2022-502019-12-00
5
2023-09-14
acute myeloid leukemia
-
2022-500974-33-00
5
2023-08-12
acute venous thromboembolism event
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2024-515146-16-00
5
2023-05-15
Colorectal surgery
-
2022-500085-96-00
5
2023-03-31
Patients with gambling disorder or sexual addiction or food addiction
-
2024-514913-37-00
11
2023-01-12
Respiratory distress
-
2022-500234-29-00
5
2022-11-28
Rheumatoid Arthritis
-
2022-500197-34-01
4
2022-11-03
Megalencephaly-CApillary malformation Polymicrogyria syndrome
-
2023-507557-16-00
5
2022-08-31
chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive